ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms

ClinicalTrials.gov ID: NCT01611194

Public ClinicalTrials.gov record NCT01611194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Brain Injury and Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms After Mild Traumatic Brain Injury (BIMA) Protocol

Study identification

NCT ID
NCT01611194
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
U.S. Army Medical Research and Development Command
Federal
Enrollment
71 participants

Conditions and interventions

Interventions

  • Hyperbaric oxygen (HBO2) at 1.5 atms Drug
  • Sham control 1.2 atms Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2012
Primary completion
Dec 31, 2014
Completion
Jan 28, 2016
Last update posted
Nov 20, 2018

2012 – 2016

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
5
Facility City State ZIP Site status
Outcomes Assessment Center, Evans Army Community Hospital Colorado Springs Colorado 80913
Evans Army Community Hospital / Hyperbaric Medicine Complex Fort Carson Colorado 80913
Camp Lejeune Jacksonville North Carolina 28542
Joint Base Lewis-McChord Fort Lewis Washington 98438
TBI Program/HBO2 Research Program Madigan Healthcare system Tacoma Washington 98431

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01611194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2018 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01611194 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →